Bone marrow counts of leukemic FLT3W51/PML-RARα mice
Mice . | Imm/Bl . | Intermediate . | Neutrophils . | Erythrocytes . | Lymphocytes . | Eosinophils . | Other . |
---|---|---|---|---|---|---|---|
Control | 2.8 | 15.7 | 25.6 | 39.9 | 13.7 | 2.6 | 0 |
PML-RARα leukemia | 81.3 | 4.5 | 0.7 | 8.7 | 4.6 | 0.3 | 0 |
PML-RARα/FLT3W51leukemia | 68.5 | 7.0 | 4.2 | 12.8 | 3.8 | 0.9 | 2.5 |
874 | 85.8 | 4 | 1.5 | 0 | 2.5 | 2.8 | 4.3 |
1019 | 64.5 | 13 | 11.5 | 4.8 | 2 | 2 | 3.5 |
1020 | 75.8 | 7.5 | 1.5 | 4.3 | 8.8 | 0 | 2.3 |
1086 | 50.8 | 2.3 | 0.5 | 36 | 4.5 | 0.8 | 2.3 |
1087 | 66.3 | 8.3 | 4.5 | 15.8 | 2.5 | 0.25 | 0.5 |
1127 | 65.5 | 10.3 | 9.3 | 10.5 | 3.3 | 0.3 | 0.5 |
1128 | 70.8 | 3.3 | 0.8 | 18 | 2.8 | 0.3 | 4 |
Mice . | Imm/Bl . | Intermediate . | Neutrophils . | Erythrocytes . | Lymphocytes . | Eosinophils . | Other . |
---|---|---|---|---|---|---|---|
Control | 2.8 | 15.7 | 25.6 | 39.9 | 13.7 | 2.6 | 0 |
PML-RARα leukemia | 81.3 | 4.5 | 0.7 | 8.7 | 4.6 | 0.3 | 0 |
PML-RARα/FLT3W51leukemia | 68.5 | 7.0 | 4.2 | 12.8 | 3.8 | 0.9 | 2.5 |
874 | 85.8 | 4 | 1.5 | 0 | 2.5 | 2.8 | 4.3 |
1019 | 64.5 | 13 | 11.5 | 4.8 | 2 | 2 | 3.5 |
1020 | 75.8 | 7.5 | 1.5 | 4.3 | 8.8 | 0 | 2.3 |
1086 | 50.8 | 2.3 | 0.5 | 36 | 4.5 | 0.8 | 2.3 |
1087 | 66.3 | 8.3 | 4.5 | 15.8 | 2.5 | 0.25 | 0.5 |
1127 | 65.5 | 10.3 | 9.3 | 10.5 | 3.3 | 0.3 | 0.5 |
1128 | 70.8 | 3.3 | 0.8 | 18 | 2.8 | 0.3 | 4 |
Bone marrow nucleated cell differential counts (%) of control, leukemic PML-RARα, and leukemic FLT3W51/PML-RARα mice are shown as mean values along with data from seven individual FLT3W51/PML-RARα mice. Erythrocytes: nucleated erythroid cells. Other: includes monocytes, macrophages, plasma cells, mast cells. Control n = 7, PML-RARα leukemias n = 6, FLT3W51/PML-RARα leukemias n = 7. Compared with control, FLT3W51/PML-RARα leukemias show a statistically significant difference for all cell types. The bone marrows of PML-RARα leukemias have significantly more immature forms/blasts than the bone marrows of FLT3W51/PML-RARα leukemias (P = .03). Some of the control and PML-RARα leukemia data have been previously reported.28 46